Cargando…

Effect of Bleomycin Hydrolase Gene Polymorphism on Late Pulmonary Complications of Treatment for Hodgkin Lymphoma

BACKGROUND: Bleomycin hydrolase (BLMH), an enzyme that inactivates bleomycin, may be a potential candidate that could influence pulmonary function in ABVD (doxorubicin, bleomycin, vinblastin, dacarbasine)–treated Hodgkin lymphoma (HL) patients. PATIENTS AND METHODS: We hypothesized that the BLMH gen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jóna, Ádám, Miltényi, Zsófia, Póliska, Szilárd, Bálint, Bálint László, Illés, Árpád
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915614/ https://www.ncbi.nlm.nih.gov/pubmed/27327270 http://dx.doi.org/10.1371/journal.pone.0157651

Ejemplares similares

Transition Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma– Our Histopathological and Clinical Experience With Patients With Intermediate Lymphoma
por: Simon, Zsófia, et al.
Publicado: (2021)

Pulmonary Toxicity of Hodgkin Lymphoma Treatment: A Prospective Single-Center Study
por: Jona, Adam, et al.
Publicado: (2021)

Changing Patterns in the Clinical Pathological Features of Hodgkin Lymphoma: A Report from Debrecen, Hungary
por: Miltényi, Zsófia, et al.
Publicado: (2011)

Real-world efficacy of brentuximab vedotin plus bendamustine as a bridge to autologous hematopoietic stem cell transplantation in primary refractory or relapsed classical Hodgkin lymphoma
por: Pinczés, László Imre, et al.
Publicado: (2020)

Employment status and health related quality of life among Hodgkin-lymphoma survivors’– results based on data from a major treatment center in Hungary
por: Magyari, Ferenc, et al.
Publicado: (2017)

Improved survival of autologous stem cell transplantation in primary refractory and relapsed Hodgkin lymphoma in the brentuximab vedotin era — real-world data from Hungary
por: Husi, Kata, et al.
Publicado: (2023)

Assessment of cognitive function in long-term Hodgkin lymphoma survivors, results based on data from a major treatment center in Hungary
por: Magyari, Ferenc, et al.
Publicado: (2022)

Late Effect of the Cervical Irradiation on Periodontal Status and Cariogen Flora in Hodgkin Lymphoma Patients
por: Simon, Zsófia, et al.
Publicado: (2011)

Rapidly Progressing Refractory Hodgkin Lymphoma: A Case Report and a Possible Explanation
por: Jóna, Ádám, et al.
Publicado: (2016)

Bleomycin in Hodgkin's Lymphoma – A Boon or a Bane? – A Retrospective Study of Bleomycin Pulmonary Toxicity in Hodgkin's Lymphoma
por: Udupa, Chethana Babu K, et al.
Publicado: (2019)

Pulmonary toxicity induced by bleomycin in a patient with Hodgkin lymphoma
por: Oliveira, CF, et al.
Publicado: (2005)

Clinical and biological prognostic factors in follicular lymphoma patients
por: Jóna, Ádám, et al.
Publicado: (2022)

Cystic Dilation of the Aqueductus Sylvii in Case of Trisomy 17p11.2—pter with the Deletion of the Terminal Portion of the Chromosome 6
por: Horváth, Emese, et al.
Publicado: (2010)

MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sjögren's syndrome
por: Chen, Ji-Qing, et al.
Publicado: (2017)

Bleomycin-induced pneumonitis in a young Ghanaian male with Hodgkin's Lymphoma
por: Dei-Adomakoh, Yvonne A, et al.
Publicado: (2020)

Corrigendum: Investigation of the Possible Role of Tie2 Pathway and TEK Gene in Asthma and Allergic Conjunctivitis
por: Gál, Zsófia, et al.
Publicado: (2020)

Investigation of the Possible Role of Tie2 Pathway and TEK Gene in Asthma and Allergic Conjunctivitis
por: Gál, Zsófia, et al.
Publicado: (2020)

Quantitative Analysis of Carbonic Anhydrase IX Uncovers Hypoxia-Related Functional Differences in Classical Hodgkin Lymphoma Subtypes
por: Matolay, Orsolya, et al.
Publicado: (2019)

Extensive proteome and functional genomic profiling of variability between genetically identical human B-lymphoblastoid cells
por: Laczik, Miklós, et al.
Publicado: (2022)

Bleomycin induced urethral stricture in Hodgkin's disease
por: Tapkire, Ritesh, et al.
Publicado: (2009)

Bleomycin-Induced Lung Toxicity in Hodgkin's Lymphoma: Risk Factors in the Positron Emission Tomography Era
por: Jennane, Selim, et al.
Publicado: (2022)

Primary Pulmonary Hodgkin Lymphoma
por: Tanveer, Shumaila, et al.
Publicado: (2015)

Hodgkin lymphoma and female fertility: a multicenter study in women treated with doxorubicin, bleomycin, vinblastine, and dacarbazine
por: Machet, Antoine, et al.
Publicado: (2022)

STAT6 Transcription Factor Is a Facilitator of the Nuclear Receptor PPARγ-Regulated Gene Expression in Macrophages and Dendritic Cells
por: Szanto, Attila, et al.
Publicado: (2010)

Bleomycin hydrolase regulates the release of chemokines important for inflammation and wound healing by keratinocytes
por: Riise, Rebecca, et al.
Publicado: (2019)

ASH2L drives proliferation and sensitivity to bleomycin and other genotoxins in Hodgkin’s lymphoma and testicular cancer cells
por: Constantin, Daniel, et al.
Publicado: (2020)

Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas
por: Gaudio, Francesco, et al.
Publicado: (2011)

Hodgkin's Lymphoma: A Review of Neurologic Complications
por: Grimm, Sean, et al.
Publicado: (2011)

Pulmonary toxicity of bleomycin.
por: Adamson, I Y
Publicado: (1976)

Correction to: ASH2L drives proliferation and sensitivity to bleomycin and other genotoxins in Hodgkin’s lymphoma and testicular cancer cells
por: Constantin, Daniel, et al.
Publicado: (2021)

Durable Remission in Hodgkin Lymphoma Treated With One Cycle of Bleomycin, Vinblastine, Dacarbazine and Two Doses of Nivolumab and Brentuximab Vedotin
por: Yohannan, Binoy, et al.
Publicado: (2022)

The active enhancer network operated by liganded RXR supports angiogenic activity in macrophages
por: Daniel, Bence, et al.
Publicado: (2014)

Analyses of association between PPAR gamma and EPHX1 polymorphisms and susceptibility to COPD in a Hungarian cohort, a case-control study
por: Penyige, Andras, et al.
Publicado: (2010)

Non-Hodgkin's lymphoma, obesity and energy homeostasis polymorphisms
por: Willett, E V, et al.
Publicado: (2005)

Early and Late Changes of MMP-2 and MMP-9 in Bleomycin-Induced Pulmonary Fibrosis
por: Kim, Ji Young, et al.
Publicado: (2009)

Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin Lymphoma
por: Vakkalanka, Bhanu, et al.
Publicado: (2011)

Late radiation toxicity in Hodgkin lymphoma patients: proton therapy's potential
por: Toltz, Allison, et al.
Publicado: (2015)

Late relapses in Hodgkin lymphoma – should we search for the needle in the haystack?
por: El‐Galaly, Tarec Christoffer, et al.
Publicado: (2022)

A national survey of videolaryngoscopes and alternative intubation devices in Hungary
por: Nagy, Bálint, et al.
Publicado: (2019)

Characteristics of pulmonary complications in non-Hodgkin’s lymphoma patients treated with rituximab-containing chemotherapy and impact on survival
por: Keefer, Kimberly, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vbe4h0tu0vks6lqhg160mmi7hp